Product availability varies by country. Consult your bioMérieux representative.
References
©2023 bioMérieux, Inc. • BIOMÉRIEUX, the BIOMÉRIEUX logo, PIONEERING DIAGNOSTICS, BIOFIRE, and FILMARRAY are used pending and/or registered trademarks belonging to bioMérieux, or one of its subsidiaries, or one of its companies • Patents • 515 Colorow Drive, Salt Lake City, UT 84108 • Tel: (800) 634-7656
bioMérieux S.A. • 69280 Marcy l’Etoile • France • www.biofiredx.com
Reduce antibiotic use1
Reduce time to antimicrobial therapy2
Lead to more targeted therapy2
Reduce downstream procedures such as endoscopies and abdominal imaging.1
Because traditional stool testing methods are slow and lack sensitivity, clinicians often must make patient management decisions without a laboratory result. Syndromic testing from the BIOFIRE GI Panel offers fast sample-to-answer turnaround and accurate results, which can:
The BIOFIRE GI Panel can streamline workflow by providing faster and more comprehensive test results. Compared to traditional diagnostic methods, stool panel testing with the BIOFIRE GI Panel may:
Reduce the number of laboratory tests on average from 3 to 13
Potentially reduce the number of send-out tests
Reduce the average time to result by 84%3
I want more information about
how the BIOFIRE GI Panel can benefit my patients.
Fill out the form below to have a representative reach out to you.
By clicking the get a quote button below, you have read and agree to the Privacy Policy and agree to receive emails from bioMérieux. You can unsubscribe at any time.
* Required Fields
*Intended for use in CLIA-moderate settings.
*Intended for use in CLIA-moderate settings.
The BIOFIRE GI Panel uses a syndromic approach to accurately detect and identify the pathogens most commonly associated with gastrointestinal infections. Fast and comprehensive, the BIOFIRE GI Panel offers a run time of about an hour, enabling high efficiency and throughput on the BIOFIRE® FILMARRAY® 2.0 and BIOFIRE® FILMARRAY® TORCH systems.
"Syndromic testing has changed the way I practice medicine."
Dr. Jaime Fergie, MD, FAAP, Director of Pediatric Infectious Diseases, Driscoll Children's Hospital, Texas, USA
The BIOFIRE GI Panel takes the syndromic approach by testing for a broad grouping of probable gastrointestinal targets in one quick test. Syndromic PCR gastrointestinal testing maximizes the chance of getting actionable answers in a clinically relevant timeframe.